UXN Co., Ltd. (XKON:337840)
South Korea · Delayed Price · Currency is KRW 8,520.00
-250.00 (-2.85%)
At close: Feb 13, 2026
UXN Co., Ltd. Market Cap
UXN Co., Ltd. has a market cap or net worth of 40.45 billion as of February 13, 2026. Its market cap has decreased by -6.07% in one year.
Market Cap
40.45B
Enterprise Value
n/a
Revenue
21.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
8,520.00
Market Cap Chart
Since November 28, 2019, UXN Co., Ltd.'s market cap has increased from 25.76B to 40.45B, an increase of 57.05%. That is a compound annual growth rate of 7.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 40.45B | -7.59% |
| Dec 30, 2025 | 43.77B | -1.99% |
| Dec 30, 2024 | 44.66B | -9.63% |
| Dec 28, 2023 | 49.42B | 10.00% |
| Dec 29, 2022 | 44.93B | -32.18% |
| Dec 30, 2021 | 66.25B | -5.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuantaMatrix | 81.69B |
| JPI Healthcare | 75.05B |
| Hironic | 74.74B |
| DRGEM | 59.49B |
| Neofect | 58.49B |
| Genoray | 54.42B |
| CU Medical Systems | 35.53B |
| Genesystem | 33.56B |